Data as of:
Price 02-03-26 16:00 ET,
Balance Sheet 2025-09-30,
Income Statement 2025-09-30,
Cash Flow 2025-09-30
Indicators
Dividend indicators
Value
Date
Pays Dividend
No
2-1-2026
Income indicators
Value
Date
EBITDA Positive
No
2-1-2026
Net Income Positive
No
2-1-2026
Avg CA Burn (Annual %)
-14.07%
2-1-2026
Avg CA Burn (Quarterly %)
-0.69%
2-1-2026
Shares Outstanding Changes
Date
Shares Outstanding
Delta
No recent share changes
Short Interest Changes
Latest short interest:
2,293,147 shares
(12.77% of float)
| Days to cover: 1.37
Date
Short Interest
Delta
Δ %
2026-02-03
2,293,147 shares
+0
+0.00%
2026-02-02
2,293,147 shares
+0
+0.00%
2026-01-30
2,293,147 shares
None
—
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
Date
Volume
Shares Outstanding
Volume / Shares
Price
2026-01-12
24,585,695
18,153,090
135.44%
$5.57
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.